Aspen Pharmacare Holdings EBIT

Aspen Pharmacare Holdings (APNHY) currently reports a EBIT of $5.9B as of June 2026. That compares with $8.9B in the prior-year period — down 33.5% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Aspen Pharmacare Holdings's EBIT history and peer comparisons.

Aspen Pharmacare Holdings's EBIT decreased from $8.9B to $5.9B — a 33.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspen Pharmacare Holdings's EBIT of $5.9B is lower than the Healthcare sector average of $110B. That is roughly 94.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Aspen Pharmacare Holdings reported $5.9B in EBIT as of June 2026. That compares with $8.9B in the prior-year period — down 33.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $5.9B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Aspen Pharmacare Holdings, and consider following APNHY for alerts when major investors trade the stock.